LEADER 01419nam  2200397Ka 450 
001 9910695715003321
005 20070426111813.0
035   $a(CKB)5470000002372634
035   $a(OCoLC)123550343
035   $a(EXLCZ)995470000002372634
100   $a20070426d2003      ua             0
101 0 $aspa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAlucino?genos y drogas disociativas$b[electronic resource] $eincluyendo la LSD, el PCP, la Ketamina, y el Dextrometorfano
210  1$a[Rockville, Md.] :$cNational Institute on Drug Abuse, National Institutes of Health,$d[2003]
215   $a1 electronic text $cHTML file
225 1 $aInstituto Nacional sobre el Abuso de Drogas serie de reportes de investigacio?n
225 1 $aNIH publicacio?n ;$vno. 03-4209(S)
300   $aTitle from title screen (viewed on Apr. 26, 2007).
300   $a"Impesa en julio del 2003."
517   $aAlucino?genos y drogas disociativas 
606   $aHallucinogenic drugs
606   $aPsychotropic drugs
606   $aHallucinogenic plants
615  0$aHallucinogenic drugs.
615  0$aPsychotropic drugs.
615  0$aHallucinogenic plants.
712 02$aNational Institute on Drug Abuse.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910695715003321
996   $aAlucino?genos y drogas disociativas$93547165
997   $aUNINA